MediPharm Labs Corp. (FRA:MLZ)
Germany flag Germany · Delayed Price · Currency is EUR
0.0318
-0.0046 (-12.64%)
At close: Dec 4, 2025

MediPharm Labs Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Cash & Equivalents
10.5811.6917.9824.1534.1119.91
Upgrade
Short-Term Investments
0.70.190.270.761.142.06
Upgrade
Cash & Short-Term Investments
11.2811.8818.2524.935.2521.97
Upgrade
Cash Growth
-16.00%-34.92%-26.73%-29.36%60.46%-44.11%
Upgrade
Accounts Receivable
6.626.885.5212.3515.7227.72
Upgrade
Other Receivables
1.10.630.350.661.26.41
Upgrade
Receivables
7.727.515.8713.0116.9234.14
Upgrade
Inventory
7.938.569.897.7810.9822.14
Upgrade
Prepaid Expenses
0.540.420.640.691.060.44
Upgrade
Other Current Assets
0.464.7120.981.342.84
Upgrade
Total Current Assets
27.9333.0836.6347.3565.5581.52
Upgrade
Property, Plant & Equipment
17.9519.1625.2718.1125.8934.14
Upgrade
Long-Term Investments
-----0.19
Upgrade
Other Intangible Assets
0.720.851.030.040.040.23
Upgrade
Other Long-Term Assets
-0.641-0.882.15
Upgrade
Total Assets
46.653.7363.9465.592.36118.23
Upgrade
Accounts Payable
4.744.242.133.542.995.55
Upgrade
Accrued Expenses
2.294.494.913.674.149.25
Upgrade
Short-Term Debt
0.350.262.110.52--
Upgrade
Current Portion of Long-Term Debt
-----7.38
Upgrade
Current Portion of Leases
0.070.080.120.080.110.32
Upgrade
Current Unearned Revenue
0.530.610.390.491.321
Upgrade
Other Current Liabilities
0.760.831.211.150.310.75
Upgrade
Total Current Liabilities
8.7410.510.869.468.8824.25
Upgrade
Long-Term Debt
-----10.54
Upgrade
Long-Term Leases
-0.050.070.030.10.22
Upgrade
Long-Term Unearned Revenue
----0.23-
Upgrade
Other Long-Term Liabilities
----04.81
Upgrade
Total Liabilities
8.7410.5510.939.499.2239.82
Upgrade
Common Stock
201.64201.21200.24191.26190.55138.51
Upgrade
Retained Earnings
-188.63-187.43-176.73-163.65-129.34-74.54
Upgrade
Comprehensive Income & Other
24.8529.429.4928.421.9414.45
Upgrade
Total Common Equity
37.8643.1853.0156.0183.1578.41
Upgrade
Shareholders' Equity
37.8643.1853.0156.0183.1578.41
Upgrade
Total Liabilities & Equity
46.653.7363.9465.592.36118.23
Upgrade
Total Debt
0.420.392.30.630.2218.46
Upgrade
Net Cash (Debt)
10.8611.4915.9524.2735.043.51
Upgrade
Net Cash Growth
-15.01%-27.99%-34.27%-30.73%897.86%-87.78%
Upgrade
Net Cash Per Share
0.030.030.040.090.140.03
Upgrade
Filing Date Shares Outstanding
420.76415.14404.05282.16273.94257.95
Upgrade
Total Common Shares Outstanding
420.76415.05401.4282.16273.54155.55
Upgrade
Working Capital
19.1922.5925.7737.8956.6757.28
Upgrade
Book Value Per Share
0.090.100.130.200.300.50
Upgrade
Tangible Book Value
37.1442.3351.9755.9783.178.19
Upgrade
Tangible Book Value Per Share
0.090.100.130.200.300.50
Upgrade
Land
1.861.862.811.521.861.89
Upgrade
Buildings
24.9724.9727.8420.9324.7925.49
Upgrade
Machinery
14.5915.118.2417.4618.8818.44
Upgrade
Construction In Progress
0.010.052.52.64.493.26
Upgrade
Leasehold Improvements
0.210.210.210.210.210.21
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.